Multiple Myeloma Clinical Trials in Boston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
  • Multiple Myeloma
  • Gilbert, Arizona
  • +23 more
2022-04-04
Apr 4, 2022
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2022-03-21
Mar 21, 2022
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2022-03-29
Mar 29, 2022
C
Active, not recruiting
  • Multiple Myeloma
  • bb2121 carfilzomib
  • +3 more
  • Scottsdale, Arizona
  • +18 more
2022-03-23
Mar 23, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +56 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Part 1 (Dose Escalation): Daratumumab
  • +3 more
  • Boston, Massachusetts
  • +7 more
2022-03-24
Mar 24, 2022
D
Recruiting
  • Multiple Myeloma
  • Sample of Blood
  • Baltimore, Maryland
  • +2 more
2022-03-22
Mar 22, 2022
A
Recruiting
  • Refractory Multiple Myeloma
  • +2 more
  • Maywood, Illinois
  • +4 more
2022-03-19
Mar 19, 2022
B
No longer available
  • Multiple Myeloma
  • Elotuzumab in combination with Lenalidomide and Dexamethasone
  • Concord, California
  • +26 more
2022-03-17
Mar 17, 2022
D
Active, not recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    2022-03-15
    Mar 15, 2022